Effect of trivalent arsenicals on cell proliferation in mouse and human microvascular endothelial cells

Toxicology Reports

Volumn 2, Issue , 2015, Pages 833-837

  Dodmane, Puttappa R ^a,b   Arnold, Lora L ^a   Pennington, Karen L ^a   Singh, Rakesh K ^a   Cardoso, Ana Paula Ferragut ^a   Cohen, Samuel M ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Arsenic; Cardiovascular; Cytotoxicity; Mitogenesis

Indexed keywords

ARSENIC TRIOXIDE; MONOMETHYLARSONOUS ACID; ORGANOARSENIC DERIVATIVE; TRIVALENT ARSENICAL; TRIVALENT DIMETHYLARSINIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LC50; MOUSE; MTT ASSAY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE;

EID: 84930937652     PISSN: 22147500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxrep.2015.05.009     Document Type: Article

References (34)

1. Ades E.W., Candal F.J., Swerlick R.A., George V.G., Summers S., Bosse D.C., Lawley T.J. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J. Invest. Dermatol. 1992, 99:683-690.
2. Barchowsky A., Dudek E.J., Treadwell M.D., Wetterhahn K.E. Arsenic induces oxidant stress and NF-kappa B activation in cultured aortic endothelial cells. Free Radical Biol. Med. 1996, 21:783-790.
3. Barchowsky A., Roussel R.R., Klei L.R., James P.E., Ganju N., Smith K.R., Dudek E.J. Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways. Toxicol. Appl. Pharmacol. 1999, 159:65-75.
4. Calabrese E.J., Iavicoli I., Calabrese V. Hormesis: its impact on medicine and health. Hum. Exp. Toxicol. 2013, 32:120-152.
5. Chen S.-C., Huang S.-Y., Lu C.-Y., Hsu Y.-H., Wang D.-C. Microvascular dysfunction with increased vascular leakage response in mice systemically exposed to arsenic. Cardiovasc. Toxicol. 2014, 14:222-231.
6. Cheng T.-J., Chuu J.-J., Chang C.-Y., Tsai W.-C., Chen K.-J., Guo H.-R. Atherosclerosis induced by arsenic in drinking water in rats through altering lipid metabolism. Toxicol. Appl. Pharmacol. 2011, 256:146-153.
7. Chiou J.-M., Wang S.-L., Chen C.-J., Deng C.-R., Lin W., Tai T.-Y. Arsenic ingestion and increased microvascular disease risk: observations from the south-western arseniasis-endemic area in Taiwan. Int. J. Epidemiol. 2005, 34:936-943.
8. Cohen S.M., Arnold L.L., Uzvolgyi E., Cano M., St John M., Yamamoto S., Lu X., Le X.C. Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat. Chem. Res. Toxicol. 2002, 15:1150-1157.
9. Cohen S.M., Arnold L.L., Eldan M., Lewis A.S., Beck B.D. Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit. Rev. Toxicol. 2006, 36:99-133.
10. Cohen S.M., Arnold L.L., Beck B.D., Lewis A.S., Eldan M. Evaluation of the carcinogenicity of inorganic arsenic. Crit. Rev. Toxicol. 2013, 43:711-752.
11. Dodmane P.R., Arnold L.L., Kakiuchi-Kiyota S., Qiu F., Liu X., Rennard S.I., Cohen S.M. Cytotoxicity and gene expression changes induced by inorganic and organic trivalent arsenicals in human cells. Toxicology 2013, 312:18-29.
12. Gentry P.R., McDonald T.B., Sullivan D.E., Shipp A.M., Yager J.W., Clewell H.J. Analysis of genomic dose-response information on arsenic to inform key events in a mode of action for carcinogenicity. Environ. Mol. Mutagen. 2010, 51:1-14.
13. Graham-Evans B., Tchounwou P.B., Cohly H.H.P. Cytotoxicity and proliferation studies with arsenic in established human cell lines: keratinocytes, melanocytes, dendritic cells, dermal fibroblasts, microvascular endothelial cells, monocytes and T-cells. Int. J. Mol. Sci. 2003, 4:13-21.
14. Harper K.N., Liu X., Hall M.N., Ilievski V., Oka J., Calancie L., Slavkovich V., Levy D., Siddique A., Alam S., Mey J.L., van Geen A., Graziano J.H., Gamble M.V. A dose-response study of arsenic exposure and markers of oxidative damage in Bangladesh. J. Occup. Environ. Med. 2014, 56:652-658.
15. Hirano S., Kobayashi Y., Cui X., Kanno S., Hayakawa T., Shraim A. The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds. Toxicol. Appl. Pharmacol. 2004, 198:458-467.
16. Jat P.S., Noble M.D., Ataliotis P., Tanaka Y., Yannoutsos N., Larsen L., Kioussis D. Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc. Natl. Acad. Sci. U.S.A 1991, 88:5096-5100.
17. Klei L.R., Barchowsky A. Positive signaling interactions between arsenic and ethanol for angiogenic gene induction in human microvascular endothelial cells. Toxicol. Sci. 2008, 102:319-327.
18. Landgraf L., Ernst P., Schick I., Köhler O., Oehring H., Tremel W., Hilger I. Anti-oxidative effects and harmlessness of asymmetric Au@Fe[U+2083]O[U+2084] Janus particles on human blood cells. Biomaterials 2014, 35:6986-6997.
19. Langley R.R., Ramirez K.M., Tsan R.Z., Arsdall M.V., Nilsson M.B., Fidler I.J. Tissue-specific Microvascular Endothelial Cell Lines from H-2Kb-tsA58 Mice for Studies of Angiogenesis and Metastasis. Cancer Res. 2003, 63:2971-2976.
20. Lemaire M., Lemarié C.A., Molina M.F., Schiffrin E.L., Lehoux S., Mann K.K. Exposure to moderate arsenic concentrations increases atherosclerosis in ApoE-/- mouse model. Toxicol. Sci. 2011, 122:211-221.
21. Mattson M.P. Hormesis defined. Ageing Res. Rev. 2008, 7:1-7.
22. Meng D., Wang X., Chang Q., Hitron A., Zhang Z., Xu M., Chen G., Luo J., Jiang B., Fang J., Shi X. Arsenic promotes angiogenesis in vitro via a heme oxygenase-1-dependent mechanism. Toxicol. Appl. Pharmacol. 2010, 244:291-299.
23. Moon K., Guallar E., Navas-Acien A. Arsenic exposure and cardiovascular disease: an updated systematic review. Curr. Atheroscler. Rep. 2012, 14:542-555.
24. Osorio-Yáñez C., Ayllon-Vergara J.C., Aguilar-Madrid G., Arreola-Mendoza L., Hernández-Castellanos E., Barrera-Hernández A., De Vizcaya-Ruiz A., Del Razo L.M. Carotid intima-media thickness and plasma asymmetric dimethylarginine in Mexican children exposed to inorganic arsenic. Environ. Health Perspect. 2013, 121:1090-1096.
25. Sanchez-Soria P., Broka D., Monks S.L., Camenisch T.D. Chronic low-level arsenite exposure through drinking water increases blood pressure and promotes concentric left ventricular hypertrophy in female mice. Toxicol. Pathol. 2012, 40:504-512.
26. Soucy N.V., Mayka D., Klei L.R., Nemec A.A., Bauer J.A., Barchowsky A. Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice. Cardiovasc. Toxicol. 2005, 5:29-41.
27. Seok J., Warren H.S., Cuenca A.G., Mindrinos M.N., Baker H.V., Weihong X., Richards D.R., McDonald-Smith G.P., Gao H., Hennessy L., Finnerty C.C., López C.M., Honari S., Moore E.E., Minei J.P., Cuschieri J., Bankey P.E., Johnson J.L., Sperry J., Nathens A.B., Billiar T.R., West M.A., Jeschke M.G., Klein M.B., Gamelli R.L., Gibran N.S., Brownstein B.H., Miller-Graziano C., Calvano S.E., Mason P.H., Cobb J.P., Rahme L.G., Lowry S.F., Maier R.V., Moldawer L.L., Herndon D.N., Davis R.W., Xiao W., Tompkins R.G. Genomic responses in mouse models poorly mimic human inflammatory diseases. PNAS 2013, 110:3507-3512.
28. Sidhu M.S., Desai K.P., Lynch H.N., Rhomberg L.R., Beck B.D., Venditti F.J. Mechanisms of action for arsenic in cardiovascular toxicity and implications for risk assessment. Toxicology 2015, 331:78-99.
29. States J.C., Srivastava S., Chen Y., Barchowsky A. Arsenic and cardiovascular disease. Toxicol. Sci. 2009, 107:312-323.
30. Straub A.C., Clark K.A., Ross M.A., Chandra A.G., Li S., Gao X., Pagano P.J., Stolz D.B., Barchowsky A. Arsenic-stimulated liver sinusoidal capillarization in mice requires NADPH oxidase-generated superoxide. J. Clin. Invest. 2008, 118:3980-3989.
31. Tokar E.J., Diwan B.A., Thomas D.J., Waalkes M.P. Tumors and proliferative lesions in adult offspring after maternal exposure to methylarsonous acid during gestation in CD1 mice. Arch. Toxicol. 2012, 86:975-982.
32. Tsuji J.S., Perez V., Garry M.R., Alexander D.D. Association of low-level arsenic exposure in drinking water with cardiovascular disease: a systematic review and risk assessment. Toxicology 2014, 323:78-94.
33. Waalkes M.P., Qu W., Tokar E.J., Kissling G.E., Dixon D. Lung tumors in mice induced by whole-life inorganic arsenic exposure at human-relevant doses. Arch. Toxicol. 2014, 88:1619-1629.
34. Xiao Y.-F., Liu S.-X., Wu D.-D., Chen X., Ren L.-F. Inhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growth factor in gastric cancer. World J. Gastroenterol. 2006, 12:5780-5786.